Naphthalenylmethoxypiperidines as renin inhibitors
申请人:Hoffmann-La Roche Inc.
公开号:US06376672B1
公开(公告)日:2002-04-23
The present invention relates to compound of formula (I)
wherein R1, R2 and R3 are as defined in the description and claims and pharmaceutically acceptable salts thereof. The compounds are useful for treating diseases associated with restenosis, glaucoma, cardiac infarct, high blood pressure and end organ damage, e.g. cardiac insufficiency and kidney insufficiency.